PROVIDER PROFILE · NPI 1265633135

Vivian Diaz Melendez

MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,887
Beneficiaries
Total drug cost
$2.1M
Distinct drugs
34
Brand share
16.6%
Top prescribed drugs
Anastrozole467 claims
Famotidine112 claims
Letrozole96 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.